MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Dual-task gait digital assessment unmask the association between dopaminergic deficits and gait parameters in early and prodromal Parkinson’s Disease

    A. Pilotto, C. Zatti, A. Rizzardi, A. Galli, C. Hansen, J. Geritz, R. Rominjnders, E. Schaeffer, M. Catania, A. Lupini, T. Comunale, E. Premi, M. Pasolini, S. Lucchini, F. Brertagna, B. Paghera, S. Caminiti, D. Perani, D. Berg, W. Maetzler, A. Padovani (Brescia, Italy)

    Objective: to explore the relationship between dopaminergic deficits and digital gait parameters alterations in de novo PD and iRBD Background: gait alterations are common features…
  • 2025 International Congress

    A Phase 2 Study of Risvodetinib in Untreated Parkinson’s Disease

    M. Werner, C. Meyer, E. Mancino, C. Klint, J. Pellecchia, A. Mcgarry, K. Kieburtz, C. Olanow (Atlanta, USA)

    Objective: Risvodetinib was evaluated in a randomized, double-blind, placebo controlled Phase 2 trial at three doses to determine the safety and tolerability in patients with…
  • 2025 International Congress

    Investigating the Neuroprotective Potential of Mushroom Extracts in Parkinson’s Disease In Vitro Models

    SEO. Seo, FAZ. Dustov (Tashkent, Uzbekistan)

    Objective: This study aims to evaluate the neuroprotective potential of various mushroom extracts in in vitro models of PD. Background: Parkinson’s disease (PD) is a…
  • 2025 International Congress

    GBA Mutations Alter Subthalamic and Nigral Neural Activity in Parkinson’s Disease

    N. Pozzi, I. Hanafi, F. Kremer, T. Musacchio, M. Reich, C. Palmisano, I. Isaias, J. Volkmann, M. Muthuraman, P. Capetian (Würzburg, Germany)

    Objective: To investigate the neurophysiological basis of Parkinson’s disease (PD) in patients with glucocerebrosidase (GBA) mutations. Background: Alterations in subthalamic neural activity are associated with…
  • 2025 International Congress

    Coping with Parkinson’s Disease through the Lens of Personality Systems Interactions (PSI) Theory: Two Case Studies

    E. Wünnenberg, N. Baumann (Trier, Germany)

    Objective: This study examines how concepts from motivation and personality research contribute to understanding coping strategies in individuals with Parkinson’s disease (PD). Background: Effective treatment…
  • 2025 International Congress

    Anterior Pallidal Stimulation for Severe Tourette Syndrome: Open Phase Outcomes

    P. Limousin, T. Foltynie, V. Lind, M. Krueger, H. Akram, J. Esperida, C. Milabo, H. Tyagi, D. Bindman, M. Silverdale, G. Auld, H. Sims, K. Chowdhury, N. Ahmed, A. King, L. Zrinzo, E. Joyce (London, United Kingdom)

    Objective: To present the open phase outcomes of a trial of anterior pallidal stimulation (antGPi DBS) on tic severity in patients with severe Tourette syndrome…
  • 2025 International Congress

    The A53T mutation in alpha-synuclein impairs astrocytic metabolism and inflammatory response

    S L. Pereira, M. Tziortziou, P. Mulica, S. Delcambre, L. Gallucci, L. Neises, M. Soudy, E. Glaab, M. Mendes, G. Dittmar, J. Meiser, A. Grünewald (Esch-sur Alzette, Luxembourg)

    Objective: This study aims to explore the impact of the A53T alpha-synuclein (α-syn) mutation on astrocytic homeostasis and metabolism in the presence of inflammatory stimuli.…
  • 2025 International Congress

    Traumatic DBS Implant exposure following head injury and its management – a case report.

    A. Uppar (BANGALORE, India)

    Objective: To present management plan employed in treatment of a case of traumatic exposure of lead wires in a known case of Idiopathic  Parkinson’s disease(PD)…
  • 2025 International Congress

    Differentiated approach to treatment and diagnosis of Parkinson’s disease.

    ZUJ. Jahongir Qizi, RMA. Abduvahabovna (Fergana, Uzbekistan)

    Objective: The anatomical and physiological characteristics of tremor in patients with Parkinson’s disease and essential tremor at the same age significantly influence diagnostic approaches, differentiation…
  • 2025 International Congress

    PADOVA: Topline results from a Phase IIb study of prasinezumab in early-stage Parkinson’s disease participants on stable symptomatic treatment

    T. Nikolcheva, G. Pagano, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, N. Pross, A. Monnet, G. Respondek, L. Rutten-Jacobs, V. Schlegel, L. Boak, G. Kerchner, P. Brundin, H. Svoboda, A. Bonni (Basel, Switzerland)

    Objective: To evaluate the effect of prasinezumab on slowing down disease progression in participants with early-stage Parkinson’s disease (PD) on stable symptomatic medication. Background: Prasinezumab…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley